Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID Reference, 4th edition, 372 pages + the daily Top 10

Breast Cancer

Free Subscription Articles published in JAMA Retrieve available abstracts of 68 articles: HTML format

Single Articles

June 2020
1. VOELKER R
   Triple-Negative Breast Cancer Drug Receives Approval.
   JAMA. 2020;323:2122.
   PubMed    
   
   
   March 2020
2. RUBIN R
   White Blood Cells Might Provide Clues to Breast Cancer Risk.
   JAMA. 2020;323:1123.
   PubMed    
   
   
   
3. KURIAN AW, Bernhisel R, Larson K, Caswell-Jin JL, et al
   Prevalence of Pathogenic Variants in Cancer Susceptibility Genes Among Women With Postmenopausal Breast Cancer.
   JAMA. 2020;323:995-997.
   PubMed    
   
   
   February 2020
4. COMSTOCK CE, Gatsonis C, Newstead GM, Snyder BS, et al
   Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
   JAMA. 2020;323:746-756.
   PubMed     Abstract available
   
   
   
5. TOSTESON ANA
   An Abbreviated MRI Protocol for Breast Cancer Screening in Women With Dense Breasts: Promising Results, but Further Evaluation Required Prior to Widespread Implementation.
   JAMA. 2020;323:719-721.
   PubMed    
   
   
   
6. QUAGLIARELLO V
   Tiny Branches.
   JAMA. 2020;323:711-712.
   PubMed    
   
   
   
7. COMSTOCK CE, Gatsonis C, Newstead GM, Snyder BS, et al
   Comparison of Abbreviated Breast MRI vs Digital Breast Tomosynthesis for Breast Cancer Detection Among Women With Dense Breasts Undergoing Screening.
   JAMA. 2020;323:746-756.
   PubMed     Abstract available
   
   
   
8. ABBASI J
   Artificial Intelligence Improves Breast Cancer Screening in Study.
   JAMA. 2020;323:499.
   PubMed    
   
   
   
9. VOELKER R
   Another Targeted Therapy for ERBB2-Positive Breast Cancer.
   JAMA. 2020;323:408.
   PubMed    
   
   
   January 2020
10. KRIST AH, Owens DK, Mangione CM
    Recommendations Related to Genetic Testing for Breast Cancer-Reply.
    JAMA. 2020;323:188-189.
    PubMed    
    
    
    
11. PINSKY PF
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:187-188.
    PubMed    
    
    
    
12. DORK T, Park-Simon TW, Hillemanns P
    Recommendations Related to Genetic Testing for Breast Cancer.
    JAMA. 2020;323:188.
    PubMed    
    
    
    
13. SLAVIN SD
    Doctoring and Deportation.
    JAMA. 2020;323:119-120.
    PubMed    
    
    
    December 2019
14. FAYANJU OLM
    Hiding in Plain Sight.
    JAMA. 2019;322:2173-2174.
    PubMed    
    
    
    September 2019
15. SLOMSKI A
    Adjuvant Therapy for HER2-Positive Breast Cancer.
    JAMA. 2019;322:1134.
    PubMed    
    
    
    
16. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;322:857-867.
    PubMed     Abstract available
    
    
    
17. NELSON HD, Fu R, Zakher B, Pappas M, et al
    Medication Use for the Risk Reduction of Primary Breast Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;322:868-886.
    PubMed     Abstract available
    
    
    
18. JIN J
    Medications to Reduce Breast Cancer Risk.
    JAMA. 2019;322:900.
    PubMed    
    
    
    
19. PACE LE, Keating NL
    Medications to Reduce Breast Cancer Risk: Promise and Limitations.
    JAMA. 2019;322:821-823.
    PubMed    
    
    
    August 2019
20. IZZO MC, Bronner G, Shields CL
    Rapidly Progressive Vision Loss in a Patient With Breast Cancer.
    JAMA. 2019 Aug 22. pii: 2749078. doi: 10.1001/jama.2019.12691.
    PubMed    
    
    
    
21. OWENS DK, Davidson KW, Krist AH, Barry MJ, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
    JAMA. 2019;322:652-665.
    PubMed     Abstract available
    
    
    
22. NELSON HD, Pappas M, Cantor A, Haney E, et al
    Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    JAMA. 2019;322:666-685.
    PubMed     Abstract available
    
    
    
23. JIN J
    Should I Be Tested for BRCA Mutations?
    JAMA. 2019;322:702.
    PubMed    
    
    
    July 2019
24. SLOMSKI A
    Preventing Cardiotoxicity Associated With Breast Cancer Therapy.
    JAMA. 2019;322:296.
    PubMed    
    
    
    
25. 
    First PI3K Inhibitor for Breast Cancer.
    JAMA. 2019;322:19.
    PubMed    
    
    
    
26. CHOI JM
    An Unexpected Asset.
    JAMA. 2019;322:29.
    PubMed    
    
    
    June 2019
27. KEATING NL, Pace LE
    New Federal Requirements to Inform Patients About Breast Density: Will They Help Patients?
    JAMA. 2019;321:2275-2276.
    PubMed    
    
    
    May 2019
28. KERLIKOWSKE K, Miglioretti DL, Vachon CM
    Discussions of Dense Breasts, Breast Cancer Risk, and Screening Choices in 2019.
    JAMA. 2019 May 31. pii: 2735405. doi: 10.1001/jama.2019.6247.
    PubMed    
    
    
    
29. CRANDALL CJ, Livingston E
    Women's Health: A New JAMA Clinical Insights Series.
    JAMA. 2019;321:1676.
    PubMed    
    
    
    
30. POLITE BN, Gluck AR, Brawley OW
    Ensuring Equity and Justice in the Care and Outcomes of Patients With Cancer.
    JAMA. 2019;321:1663-1664.
    PubMed    
    
    
    April 2019
31. RUDDY KJ, Ganz PA
    Treatment of Nonmetastatic Breast Cancer.
    JAMA. 2019 Apr 12. pii: 2731086. doi: 10.1001/jama.2019.3927.
    PubMed    
    
    
    
32. VOELKER R
    Quick Uptakes: Taking the Uncertainty Out of Interpreting BRCA Variants.
    JAMA. 2019;321:1340-1341.
    PubMed    
    
    
    February 2019
33. SLOMSKI A
    BMI Not a Good Proxy for Breast Cancer Risk.
    JAMA. 2019;321:735.
    PubMed    
    
    
    January 2019
34. WAKS AG, Winer EP
    Breast Cancer Treatment: A Review.
    JAMA. 2019;321:288-300.
    PubMed     Abstract available
    
    
    
35. WAKS AG, Winer EP
    Breast Cancer Treatment.
    JAMA. 2019;321:316.
    PubMed    
    
    
    
36. DOMCHEK SM
    Risk-Reducing Mastectomy in BRCA1 and BRCA2 Mutation Carriers: A Complex Discussion.
    JAMA. 2019;321:27.
    PubMed    
    
    
    December 2018
37. SLOMSKI A
    Chemoimmunotherapy for Triple-Negative Breast Cancer.
    JAMA. 2018;320:2521.
    PubMed    
    
    
    
38. HERSHMAN DL, Unger JM, Crew K
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2270-2271.
    PubMed    
    
    
    
39. LIU C, Zhang H, Sun C
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2270.
    PubMed    
    
    
    
40. MAO JJ, Farrar JT
    Acupuncture for Aromatase Inhibitor-Related Joint Pain Among Breast Cancer Patients.
    JAMA. 2018;320:2269-2270.
    PubMed    
    
    
    August 2018
41. LEE GK, Sheckter CC
    Breast Reconstruction Following Breast Cancer Treatment-2018.
    JAMA. 2018 Aug 31. pii: 2701789. doi: 10.1001/jama.2018.12190.
    PubMed    
    
    
    
42. GROSS AL, Blot WJ, Visvanathan K
    BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
    JAMA. 2018;320:597-598.
    PubMed    
    
    
    
43. ABBASI J
    Can Acupuncture Keep Women on Their Breast Cancer Drugs?
    JAMA. 2018 Aug 8. pii: 2696922. doi: 10.1001/jama.2018.11068.
    PubMed    
    
    
    July 2018
44. SLOMSKI A
    Many Women With Early Breast Cancer May Not Need Chemotherapy.
    JAMA. 2018;320:332.
    PubMed    
    
    
    
45. HERSHMAN DL, Unger JM, Greenlee H, Capodice JL, et al
    Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women With Early-Stage Breast Cancer: A Randomized Clinical Trial.
    JAMA. 2018;320:167-176.
    PubMed     Abstract available
    
    
    
46. ABBASI J
    Immunotherapy Leads to Complete Regression in Late-Stage Breast Cancer.
    JAMA. 2018;320:127.
    PubMed    
    
    
    June 2018
47. GILL J, Obley AJ, Prasad V
    Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
    JAMA. 2018;319:2377-2378.
    PubMed    
    
    
    
48. PLEVRITIS SK, Berry DA, Mandelblatt JS
    Contributions of Screening and Treatment to Mortality From Breast Cancer-Reply.
    JAMA. 2018;319:2336.
    PubMed    
    
    
    
49. CHEN HH
    Contributions of Screening and Treatment to Mortality From Breast Cancer.
    JAMA. 2018;319:2335-2336.
    PubMed    
    
    
    May 2018
50. KEATING NL, Pace LE
    Breast Cancer Screening in 2018: Time for Shared Decision Making.
    JAMA. 2018;319:1814-1815.
    PubMed    
    
    
    April 2018
51. BEJNORDI BE, Litjens G, van der Laak JA
    Machine Learning Compared With Pathologist Assessment-Reply.
    JAMA. 2018;319:1726.
    PubMed    
    
    
    
52. VAN SMEDEN M, Van Calster B, Groenwold RHH
    Machine Learning Compared With Pathologist Assessment.
    JAMA. 2018;319:1725-1726.
    PubMed    
    
    
    March 2018
53. KATZ SJ, Jagsi R, Morrow M
    Reducing Overtreatment of Cancer With Precision Medicine: Just What the Doctor Ordered.
    JAMA. 2018;319:1091-1092.
    PubMed    
    
    
    February 2018
54. PEACHMAN RR
    Weighing the Risks and Benefits of Hormonal Contraception.
    JAMA. 2018 Feb 28. pii: 2673941. doi: 10.1001/jama.2018.0448.
    PubMed    
    
    
    
55. HENNEMAN JR
    In Shadow and Light-Images of Transformation Through Breast Cancer.
    JAMA. 2018;319:532-534.
    PubMed    
    
    
    January 2018
56. BALLMAN KV, McCall LM, Giuliano AE
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer-Reply.
    JAMA. 2018;319:306-307.
    PubMed    
    
    
    
57. UNO H, Hassett MJ, Wei LJ
    Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer.
    JAMA. 2018;319:306.
    PubMed    
    
    
    
58. PLEVRITIS SK, Munoz D, Kurian AW, Stout NK, et al
    Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012.
    JAMA. 2018;319:154-164.
    PubMed     Abstract available
    
    
    
59. MANSON JE, Aragaki AK, Rossouw JE
    Menopausal Estrogen Therapy and Breast Cancer Mortality-Reply.
    JAMA. 2018;319:193-194.
    PubMed    
    
    
    
60. HICKEY M, McNamara HC, Mishra GD
    Menopausal Estrogen Therapy and Breast Cancer Mortality.
    JAMA. 2018;319:193.
    PubMed    
    
    
    December 2017
61. EHTESHAMI BEJNORDI B, Veta M, Johannes van Diest P, van Ginneken B, et al
    Diagnostic Assessment of Deep Learning Algorithms for Detection of Lymph Node Metastases in Women With Breast Cancer.
    JAMA. 2017;318:2199-2210.
    PubMed     Abstract available
    
    
    
62. GOLDEN JA
    Deep Learning Algorithms for Detection of Lymph Node Metastases From Breast Cancer: Helping Artificial Intelligence Be Seen.
    JAMA. 2017;318:2184-2186.
    PubMed    
    
    
    November 2017
63. ENGELHARDT KE, Barnard C, Bilimoria KY
    Wrong-Site Surgery.
    JAMA. 2017;318:2033-2034.
    PubMed    
    
    
    
64. THOMAS R, Fysh ETH, Smith NA, Lee P, et al
    Effect of an Indwelling Pleural Catheter vs Talc Pleurodesis on Hospitalization Days in Patients With Malignant Pleural Effusion: The AMPLE Randomized Clinical Trial.
    JAMA. 2017;318:1903-1912.
    PubMed     Abstract available
    
    
    September 2017
65. SLOMSKI A
    Low-Fat Diet Reduces Mortality After Breast Cancer.
    JAMA. 2017;318:1099.
    PubMed    
    
    
    
66. GIULIANO AE, Ballman KV, McCall L, Beitsch PD, et al
    Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    JAMA. 2017;318:918-926.
    PubMed     Abstract available
    
    
    
67. LIVINGSTON EH, Li HC
    Breast Cancer Surgery: Less Is More.
    JAMA. 2017;318:909-911.
    PubMed    
    
    
    
68. MCNEIL M
    Menopausal Hormone Therapy: Understanding Long-term Risks and Benefits.
    JAMA. 2017;318:911-913.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: